Stimulus-induced gamma rhythms are weaker in human elderly with Mild Cognitive Impairment and Alzheimer's Disease

  1. Dinavahi VPS Murty
  2. Keerthana Manikandan
  3. Wupadrasta Santosh Kumar
  4. Ranjini Garani Ramesh
  5. Simran Purokayastha
  6. Bhargavi Nagendra
  7. Abhishek M. L.
  8. Aditi Balakrishnan
  9. Mahendra Javali
  10. Naren Prahalada Rao
  11. Supratim Ray  Is a corresponding author
  1. Indian Institute of Science, India
  2. MS Ramaiah Medical College & Memorial Hospital, India
  3. National Institute of Mental Health and Neurosciences, India

Abstract

Alzheimer's Disease (AD) in elderly adds substantially to socio-economic burden necessitating early diagnosis. While recent studies in rodent models of AD have suggested diagnostic and therapeutic value for gamma rhythms in brain, the same has not been rigorously tested in humans. In this case-control study, we recruited a large population (N=244; 106 females) of elderly (>49 years) subjects from the community, who viewed large gratings that induced strong gamma oscillations in their electroencephalogram (EEG). These subjects were classified as healthy (N=227), mild-cognitively-impaired (MCI; N=12) or AD (N=5) based on clinical history and Clinical Dementia Rating scores. Surprisingly, stimulus-induced gamma rhythms, but not alpha or steady-state visually evoked responses, were significantly lower in MCI/AD subjects compared to their age and gender matched controls. This reduction was not due to differences in eye-movements or baseline power. Our results suggest that gamma could be used as potential screening tool for MCI/AD in humans.

Data availability

All spectral analyses were performed using Chronux toolbox (version 2.10), available at http://chronux.org. Relevant data and codes are available at the following GitHub repository: https://github.com/supratimray/TLSAEEGProjectPrograms.

Article and author information

Author details

  1. Dinavahi VPS Murty

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  2. Keerthana Manikandan

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  3. Wupadrasta Santosh Kumar

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  4. Ranjini Garani Ramesh

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  5. Simran Purokayastha

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6096-1477
  6. Bhargavi Nagendra

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  7. Abhishek M. L.

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  8. Aditi Balakrishnan

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  9. Mahendra Javali

    Department of Neurology, MS Ramaiah Medical College & Memorial Hospital, Bangalore, India
    Competing interests
    The authors declare that no competing interests exist.
  10. Naren Prahalada Rao

    Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
    Competing interests
    The authors declare that no competing interests exist.
  11. Supratim Ray

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    For correspondence
    sray@iisc.ac.in
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1968-1382

Funding

Tata Trusts

  • Naren Prahalada Rao
  • Supratim Ray

Wellcome Trust/DBT India Alliance (Intermediate fellowship 500145/Z/09/Z)

  • Supratim Ray

Wellcome Trust/DBT India Alliance (Senior fellowship IA/S/18/2/504003)

  • Supratim Ray

Department of Biotechnology, Ministry of Science and Technology, India (DBT-IISc Partnership Programme)

  • Supratim Ray

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: We obtained informed consent from all participants before the experiment. The Institute Human Ethics Committees of Indian Institute of Science (IHEC numbers: original: 22/2014, revised: 7-15092017), NIMHANS, and M S Ramaiah Hospital, Bangalore approved all procedures.

Copyright

© 2021, Murty et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,782
    views
  • 548
    downloads
  • 51
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dinavahi VPS Murty
  2. Keerthana Manikandan
  3. Wupadrasta Santosh Kumar
  4. Ranjini Garani Ramesh
  5. Simran Purokayastha
  6. Bhargavi Nagendra
  7. Abhishek M. L.
  8. Aditi Balakrishnan
  9. Mahendra Javali
  10. Naren Prahalada Rao
  11. Supratim Ray
(2021)
Stimulus-induced gamma rhythms are weaker in human elderly with Mild Cognitive Impairment and Alzheimer's Disease
eLife 10:e61666.
https://doi.org/10.7554/eLife.61666

Share this article

https://doi.org/10.7554/eLife.61666

Further reading

    1. Medicine
    2. Neuroscience
    Tomohiro Umeda, Ayumi Sakai ... Takami Tomiyama
    Research Article

    Neurodegenerative diseases are age-related disorders characterized by the cerebral accumulation of amyloidogenic proteins, and cellular senescence underlies their pathogenesis. Thus, it is necessary for preventing these diseases to remove toxic proteins, repair damaged neurons, and suppress cellular senescence. As a source for such prophylactic agents, we selected zizyphi spinosi semen (ZSS), a medicinal herb used in traditional Chinese medicine. Oral administration of ZSS hot water extract ameliorated Aβ and tau pathology and cognitive impairment in mouse models of Alzheimer’s disease and frontotemporal dementia. Non-extracted ZSS simple crush powder showed stronger effects than the extract and improved α-synuclein pathology and cognitive/motor function in Parkinson’s disease model mice. Furthermore, when administered to normal aged mice, the ZSS powder suppressed cellular senescence, reduced DNA oxidation, promoted brain-derived neurotrophic factor expression and neurogenesis, and enhanced cognition to levels similar to those in young mice. The quantity of known active ingredients of ZSS, jujuboside A, jujuboside B, and spinosin was not proportional to the nootropic activity of ZSS. These results suggest that ZSS simple crush powder is a promising dietary material for the prevention of neurodegenerative diseases and brain aging.

    1. Medicine
    Hyun Beom Song, Laura Campello ... Anand Swaroop
    Research Advance

    Inherited retinal degenerations (IRDs) constitute a group of clinically and genetically diverse vision-impairing disorders. Retinitis pigmentosa (RP), the most common form of IRD, is characterized by gradual dysfunction and degeneration of rod photoreceptors, followed by the loss of cone photoreceptors. Recently, we identified reserpine as a lead molecule for maintaining rod survival in mouse and human retinal organoids as well as in the rd16 mouse, which phenocopy Leber congenital amaurosis caused by mutations in the cilia-centrosomal gene CEP290 (Chen et al., 2023). Here, we show the therapeutic potential of reserpine in a rhodopsin P23H rat model of autosomal dominant RP. At postnatal day (P) 68, when males and females are analyzed together, the reserpine-treated rats exhibit higher rod-derived scotopic b-wave amplitudes compared to the controls with little or no change in scotopic a-wave or cone-derived photopic b-wave. Interestingly, the reserpine-treated female rats display enhanced scotopic a- and b-waves and photopic b-wave responses at P68, along with a better contrast threshold and increased outer nuclear layer thickness. The female rats demonstrate better preservation of both rod and cone photoreceptors following reserpine treatment. Retinal transcriptome analysis reveals sex-specific responses to reserpine, with significant upregulation of phototransduction genes and proteostasis-related pathways, and notably, genes associated with stress response. This study builds upon our previously reported results reaffirming the potential of reserpine for gene-agnostic treatment of IRDs and emphasizes the importance of biological sex in retinal disease research and therapy development.